|
Romiplostim N01 Clinical Trials
3 actively recruiting trials
Pipeline
Phase 1: 1Phase 2: 2
Top Sponsors
- Institute of Hematology & Blood Diseases Hospital, China1
- First Affiliated Hospital of Zhejiang University1
- Anhui Provincial Hospital1
Indications
- Cancer3
- Romiplostim N011
- HSCT1
- Delayed Platelet Engraftment1
- Platelet Recovery After Umbilical Cord Blood Transplantation1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.